Cooper A J
University of Western Ontario, London.
Can J Psychiatry. 1991 Oct;36(8):574-8. doi: 10.1177/070674379103600805.
Forty men with organic or psychogenic impotence, who were highly motivated for treatment, were offered instruction in the intracavernosal (I-C) self-injection of papaverine and regular ongoing supervision by the investigator. Twenty declined immediately, citing a number of reasons, notably qualms about pain of the injection, side-effects and the unnaturalness of the method. Eleven patients discontinued the drug within 11 months; nine used it for at least one year, and all were continuing with it albeit less frequently at the time of assessment. Those who discontinued treatment differed significantly from those who did not; the latter initially used the drug less frequently (less than once per month), did not have a regular sexual partner or had a poor relationship with their sexual partner, and reported a decline in libido during use of the drug. The findings suggest that I-C papaverine, although effective in treating impotence, is not a panacea, and a large percentage of users (55% in our study) are likely to discontinue the drug within a relatively short period of time.
四十名患有器质性或心因性阳痿且积极寻求治疗的男性,接受了海绵体内(I-C)注射罂粟碱的指导,并由研究者进行定期持续监督。二十人立即拒绝,理由有很多,特别是对注射疼痛、副作用以及该方法的非自然性感到疑虑。十一名患者在11个月内停药;九名患者使用该药物至少一年,并且在评估时所有人都仍在使用,尽管使用频率降低了。停药的患者与未停药的患者有显著差异;后者最初使用药物的频率较低(每月少于一次),没有固定的性伴侣或与性伴侣关系不佳,并且在使用药物期间报告性欲下降。研究结果表明,海绵体内注射罂粟碱虽然对治疗阳痿有效,但并非万灵药,并且很大比例的使用者(我们研究中的55%)可能在相对较短的时间内停药。